Back to Results
First PageMeta Content
Quality-adjusted life year / Visual prosthesis / Cost–utility analysis / Retinal Degeneration / Retinitis pigmentosa / Incremental cost-effectiveness ratio / Pharmacoeconomics / Macular degeneration / Retina / Health / Medicine / Health economics


Results at seven years after the use of intracamerular cefazolin as an endophthalmitis prophylaxis in cataract surgery
Add to Reading List

Open Document

File Size: 1,14 MB

Share Result on Facebook

City

Santos / Paris / Manchester / Exeter / Maastricht / Redmond / Pisa / Fort Lauderdale / Lausanne / /

Company

Argus / Microsoft Corporation / AMD / Second Sight Medical Products Inc. / GE / Google / Safran AB / BioMed Central Ltd. / Creative Commons / /

Continent

Europe / /

Country

Switzerland / Netherlands / France / Canada / United Kingdom / Wales / Germany / Italy / United States / /

Currency

GBP / USD / EUR / CAD / IDR / /

/

Facility

Royal Eye Hospital / University of Manchester / University of Exeter Medical School / Bocconi University / RWTH Aachen University / Santa Chiara Hospital / /

Holiday

Assumption / /

IndustryTerm

healthcare payer / health technology / software updates / orphan products / reference network / healthcare technology / health technology assessment / assessment tools / healthcare / healthcare systems / implantable device / licensed device / healthcare payers / direct healthcare costs / orphan medicinal products / online submission / technology appraisal / /

MedicalCondition

rare diseases / Retinitis Pigmentosa / healthy ganglion / Macular Degeneration / Decreased depression / injury / chronic stimulations / FLORA functional low vision / both low vision / ocular diseases / hypotonia / low vision / depression / conventional low vision / RP a rare disease / functional low vision / severe external retinal degeneration / MS / blindness / dry eye disease / disease / Visual deficiency / rare disease / bilateral retinal degeneration / legal blindness / chronic microelectronic retinal prosthesis / eye disease / /

MedicalTreatment

alternative therapy / /

Movie

Quality of life / /

Organization

LP RP / European Parliament / medicare / Organization for Economic Cooperation and Development / International Society for Pharmacoeconomics / 6Manchester Royal Eye Hospital / FDA / European Union / International Society for Pharmacoeconomics and Outcome Research / 5Ophthalmology Department / University of Manchester / Manchester / Council Regulation / Santa Chiara Hospital / RWTH Aachen University / Aachen / 2Public Management & Policy Department / University of Exeter Medical School / International Alliance / Bocconi University / Milan / Outcome Research / /

Person

Paulo Eduardo / Amit Kukrja / Anil Vaidya / Van Boemel / Arch Clin / Arch Ophthalmol / /

Position

author / same author / Directorate General / Singer / /

Product

Microsoft Corporation Portable Audio Device / B52 / Argus II / Argus II / a retinal prosthesis system for treating RP / /

ProgrammingLanguage

BETA / /

ProvinceOrState

RP / Washington / Florida / /

PublishedMedium

the Argus / Health Economics / /

Technology

healthcare technology / Alpha / health technology / genomics / AV / pdf / http / simulation / then explored simultaneously using 1000 Monte Carlo simulation / /

URL

http /

SocialTag